A provision in SB 848 that was enacted earlier this year requires pharmacies to report any opioid as being used for the treatment of acute or chronic pain, and also to report any non-opioid controlled substance prescription. Since the bill included an emergency clause, it took effect immediately in May. The Office of the Bureau of Narcotics and Dangerous Drugs Control (OBNDDC) notified NACDS last week that that they will give all pharmacies enough time to make the necessary programming changes to the Prescription Monitoring Program, but warnings will be sent starting on Sunday, September 1, if the data is not reported. OBNDDC did confirm that they will not begin taking enforcement actions on errors until Wednesday, January 1, 2020.
For more information, contact NACDS’ Mary Staples at 817-442-1155.